New weekly shot shows promise for obesity treatment in early trial
NCT ID NCT07022977
First seen Jan 24, 2026 · Last updated May 12, 2026 · Updated 12 times
Summary
This study tests a new medicine called MET233, given as a weekly injection, to see if it is safe and helps with weight loss. It includes 120 adults who are overweight or have obesity but are otherwise healthy. Participants receive either the drug or a placebo for up to 12 weeks, and researchers monitor side effects, how the drug moves in the body, and weight changes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY AND OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
MET233 Research Site 001
Cypress, California, 90630, United States
Conditions
Explore the condition pages connected to this study.